IMAGE

Fig. 2

ID
ZDB-IMAGE-080529-67
Source
Figures for Kanungo et al., 2003
Image
Figure Caption

Fig. 2 MO knockdown of gelsolin ventralizes embryos. Embryos 30 hpf after microinjection of control MO (2.5 ng/E; a) and gelsolin MO (b) are shown. Arrows indicate the location of the eyes. Embryos injected with control (c) or gelsolin MO (1 ng/E; d) are shown 72 hpf. Gelsolin MO resulted in ventralized embryos (b) and hatchlings with smaller and less pigmented eyes (d). The effect of different doses of gelsolin MO on the gelsolin and actin levels was determined by immunoblotting of embryo extracts prepared 8 h after MO injection (e; ref. 14). A representative immunoblot of four separate experiments is shown. The phenotypic effect of different doses of the gelsolin MO is summarized (f). Histological analyses using hematoxylin/eosin staining compare the normal and reduced development of anterior cephalic structures in control (g) and gelsolin MO-injected (h) embryos at 30 hpf. Locations of brain (B), eye (E), and yolk mass (Y) are indicated. Gelsolin mRNA (50 pg/E) injection results in dorsalized embryos (i and j). Arrows indicate duplicated posterior axial regions. Microinjection of human plasma gelsolin protein (4 ng/E) resulted in axis duplication (k). Arrows indicate duplicated anterior axial region including head and eyes. Histological section (l) of the embryo with duplicated axes showing notochord (nc) and optic cup (oc). Coinjection of gelsolin MO (2.5 ng/E) with 4 ng of human gelsolin protein (m), or with gelsolin mRNA (50 pg/E; n), or with chordin mRNA (50 pg/E; o) rescued the gelsolin MO-injected phenotypes. Embryos at 30 hpf are shown.

Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Proc. Natl. Acad. Sci. USA